Real-world Evidence From GARFIELD-AF Shows Superior Reduction in Mortality With Non-vitamin K Antagonists Oral Anticoagulants (NOACs) vs. Vitamin K Antagonists (VKAs) in Newly Diagnosed Atrial Fibrillation

MUNICH, August 28, 2018 /PRNewswire/ -- High-risk patients on anticoagulants (AC) for stroke prevention also have 17% fewer deaths over 2 years of follow-up than patients who are not treated with AC Patients who receive AC plus add-on antiplatelet therapy (AP)...

from PR Newswire: //https://ift.tt/2wm6e4p